Jessica Leyva-Rangel, PhD
Dr. Leyva-Rangel has been working at Boston Children’s Hospital since 2020. First, as lead technologist in the Nephrology department where she developed expertise in basic immunology and assisted with the generation and maintenance of transgenic animals and was involved in the maintenance of laboratory protocols. Then, she joined the Division of Infectious Diseases where she conducted and developed pre-clinical assays for the phase 1 clinical trial aiming to develop a Pneumococcal whole cell vaccine. Dr. Leyva-Rangel is currently the research project manager of the U19 IMPACT-CETR grant which received $25 million in funding from NIAID/NIH and will focus on developing preventive strategies against three major bacterial pathogens: Staphylococcus aureus, Pseudomonas aeruginosa, and Klebsiella pneumoniae.